Category: Gastroenterology and Endoscopy

Women in GI Network advocates for industry equality

In 2021, Miami-based Gastro Health launched the Women in GI Network, led by Asma Khapra, MD, to promote gender equity in gastroenterology, according to a Sept. 16 press release sent to Becker’s. 

Waud Capital sells controlling ownership stake in GI Alliance

Waud Capital Partners LLC. has sold its controlling ownership stake in the nation’s largest GI practice management company, GI Alliance. 

Ryan Reynolds, Rob McElhenney get colonoscopies on camera

Actors Ryan Reynolds and Rob McElhenney recorded themselves receiving colonoscopies to raise awareness of increasing colon cancer diagnoses among people younger than 50, CNN reported Sept. 14.

17 hospitals ranked top 25 gastroenterology hospitals 3+ years in a row

Every year, U.S. News & World Report releases a ranking of the top hospitals for gastroenterology worldwide. In 2021, 2022 and 2023, a total of 17 hospitals were ranked in the top 25 for all three years. 

Acceptance rates at the top 20 universities for gastroenterology and hepatology

A 2022 report from U.S. News & World Report ranked the top 20 medical schools for gastroenterology and hepatology for the year, with the University of California San Diego topping the list. 

GI Alliance finalizes $785M physician-led buyout

Southlake, Texas-based GI Alliance has finalized its physician-led buyout facilitated by a $785 million investment from private equity firm Apollo Hybrid Value.

Top 25 hospitals for gastroenterology in 2023: Report

Rochester, Minn.-based Mayo Clinic has been named the top hospital in the world for gastroenterology in 2023, according to a new report from Newsweek. 

Society of American Gastrointestinal and Endoscopic Surgeons extends partnership with video tech provider

The Society of American Gastrointestinal and Endoscopic Surgeons has extended its partnership with Theator, the creator of a video surgical intelligence platform that can analyze surgical video data.  

Takeda launches prognostic Crohn’s disease blood test

Biopharmaceutical company Takeda has announced the launch of its Cdpath program, which uses a blood test to predict someone’s risk for developing Crohn’s disease within the next three years, according to a Sept. 14 press release sent to Becker’s. …

10 of the biggest GI deals in 2022

Here are 10 of the biggest gastroenterology deals since Jan. 1: